Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,539,539
-$870,241 QoQ
Shares Held
395,038
-46.0% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,232,542,246 across 191 Biotechnology names. VIR ranks #90 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in VIR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,539,539 | 395,038 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,409,780 | 731,307 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,109,275 | 194,269 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,065,395 | 211,388 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,385,002 | 213,735 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,608,722 | 219,172 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,002,930 | 267,414 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,744,288 | 308,347 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,267,694 | 322,576 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,146,284 | 312,752 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,914,585 | 311,055 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,774,033 | 276,153 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,063,352 | 303,539 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $7,768,271 | 306,925 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $11,131,828 | 577,377 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,045,922 | 315,898 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $459,770 | 17,876 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $595,893 | 14,232 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $581,079 | 13,352 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $640,738 | 13,552 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $689,427 | 13,447 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||